Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 1.47c
Percent of AMI patients with left ventricular systolic dysfunction prescribed ACE inhibitor or angiotensin receptor blocker at discharge, all payers, by State, 2004 and 2006
State 2006 2004
Percenta Percenta
Totalb 82 77
Alabama 78 72
Alaska 83 78
Arizona 84 78
Arkansas 79 72
California 82 73
Colorado 91 84
Connecticut 78 79
Delaware 84 80
District of Columbia 86 84
Florida 83 71
Georgia 76 70
Hawaii 74 67
Idaho 83 79
Illinois 80 76
Indiana 80 77
Iowa 88 76
Kansas 79 78
Kentucky 73 71
Louisiana 82 78
Maine 85 75
Maryland 85 75
Massachusetts 88 86
Michigan 84 78
Minnesota 87 77
Mississippi 79 78
Missouri 76 79
Montana 86 DSU
Nebraska 88 70
Nevada 82 80
New Hampshire 90 86
New Jersey 85 81
New Mexico 69 65
New York 85 80
North Carolina 77 76
North Dakota 75 87
Ohio 84 80
Oklahoma 81 74
Oregon 87 77
Pennsylvania 75 68
Rhode Island 87 83
South Carolina 84 75
South Dakota 82 81
Tennessee 83 68
Texas 83 71
Utah 77 71
Vermont 84 97
Virginia 83 76
Washington 83 76
West Virginia 74 70
Wisconsin 83 78
Wyoming 95 92

a State average percent precalculated and supplied as part of the Hospital Compare database. The 2004 data reflect care for the period January to June 2004; the 2006 data reflect care for the period April 2005 to March 2006.

b Estimates are the means of reporting States.

DSU - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Key: AMI: acute myocardial infarction; ACE: angiotensin converting enzyme.

Source: Centers for Medicare & Medicaid Services, Hospital Compare.

 

AHRQ Advancing Excellence in Health Care